IMM 11.9% 29.5¢ immutep limited

Media, page-555

  1. 2,508 Posts.
    lightbulb Created with Sketch. 279

    Accelerated Approval
    A drug granted Accelerated Approval is approved based on evidence of impact on a surrogate endpoint rather than evidence of impact on the actual clinical benefit the drug is intended to provide.
    Priority review
    The drug must demonstrate, through clinical trial data or other scientifically valid information, the potential to provide a significant improvement in safety or effectiveness over existing treatments.

    For mine it’s just a matter of which one comes next , accelerated approval or priority review?

    DYOR
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.040(11.9%)
Mkt cap ! $428.5M
Open High Low Value Volume
32.0¢ 33.0¢ 28.0¢ $7.278M 23.75M

Buyers (Bids)

No. Vol. Price($)
4 53192 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 41048 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.